United States · FDA National Drug Code directory
TASCENSO ODT
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70709-062_fdba8834-a431-46b5-8dd2-5f57fb1efc79
- Product NDC
- 70709-062
- Form
- TABLET, ORALLY DISINTEGRATING
- Composition / generic term
- Fingolimod Lauryl Sulfate
- Labeler
- Cycle Pharmaceuticals Ltd
- Marketing category
- NDA
- Marketing start / end (source format)
- 20230201
- Source listing expiry
- 20271231
Source-listed ingredients
- FINGOLIMOD LAURYL SULFATE — .25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 3 BLISTER PACK in 1 CARTON (70709-062-30) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK · 70709-062-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →